MoneyWorks4Me

Biocon - Quaterly Results

28 Apr 2022 Evaluate
The revenue zoomed 5.31% to Rs. 5177.00 millions for the quarter ended March 2022 as compared to Rs. 4916.00 millions during the corresponding quarter last year.The Net Profit of the company slipped to Rs. 381.00 millions from Rs. 677.00 millions, a decline of -43.72% on QoQ basis.Operating Profit reported a sharp decline to 873.00 millions from 1118.00 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 5177.00 4916.00 5.31 17382.00 20284.00 -14.31 17382.00 20284.00 -14.31
Other Income 608.00 449.00 35.41 1872.00 1502.00 24.63 1872.00 1502.00 24.63
PBIDT 873.00 1118.00 -21.91 2483.00 4627.00 -46.34 2483.00 4627.00 -46.34
Interest 0.00 1.00 0.00 4.00 4.00 0.00 4.00 4.00 0.00
PBDT 873.00 1117.00 -21.84 2479.00 4623.00 -46.38 2479.00 4623.00 -46.38
Depreciation 281.00 254.00 10.63 1082.00 1035.00 4.54 1082.00 1035.00 4.54
PBT 592.00 863.00 -31.40 1397.00 3588.00 -61.06 1397.00 3588.00 -61.06
TAX 211.00 186.00 13.44 536.00 783.00 -31.55 536.00 783.00 -31.55
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 381.00 677.00 -43.72 861.00 2805.00 -69.30 861.00 2805.00 -69.30
Equity 6003.00 6000.00 0.05 6003.00 6000.00 0.05 6003.00 6000.00 0.05
PBIDTM(%) 16.86 22.74 -25.85 14.28 22.81 -37.38 14.28 22.81 -37.38
Peers
Company Name CMP
Sun Pharma. Inds. 1782.00
Dr. Reddys Labs. 1208.00
Cipla 1334.00
Lupin 2010.00
Zydus Lifesciences 1138.50
View more..